Home › Companies › Immunocore Holdings Plc › 2025-2026

Immunocore Holdings Plc 2025-2026 Proxy Voting Records

Compiled from SEC Form N-PX filings and Immunocore Holdings Plc’s Form 8-K, filed 2026-05-27 (Item 5.07 on EDGAR). Page generated 02 October 2026.

  • 10Reported items
  • 156Asset managers
  • 879Fund votes
  • 2026-05-27Meeting date

Proxy season: 2023-2024 2024-2025 2025-2026

Explore Immunocore Holdings Plc in the interactive database Compare manager voting policies

Official 2025-2026 meeting results reported by Immunocore Holdings Plc

These tallies are Immunocore Holdings Plc’s own, as disclosed to the U.S. Securities and Exchange Commission on Form 8-K, filed 2026-05-27 (Item 5.07, “Submission of Matters to a Vote of Security Holders”). They cover every share voted at the meeting, not just the funds that file Form N-PX.

Immunocore Holdings Plc — official shareholder meeting results, meeting held 2026-05-27
Ballot itemForAgainst AbstainWithheldBroker non-votesOutcome
Resolution 2 : To re-appoint as a director of the Company William Pao, M.D., Ph.D. 38,040,755254,8528,233 ---- Majority: yes
Resolution 3 : To re-appoint as a director of the Company Kristine Peterson. 29,537,8008,744,38321,657 ---- Majority: yes
Resolution 4: To approve, on an advisory basis, the compensation of the Company's named executive officers, as disclosed in the Proxy Statement. 29,682,1698,600,02921,642 ---- Majority: yes
Resolution 5: To ratify the appointment of Deloitte LLP, a limited liability partnership organized under the laws of England, as the Company's U.S. independent registered public accounting firm for the year ending December 31, 2026. 38,294,6669848,190 ---- Majority: yes
Resolution 6 : To re-appoint Deloitte LLP, a limited liability partnership organized under the laws of England, as the Company's U.K. statutory auditors, to hold office until the conclusion of the next annual general meeting of shareholders 38,294,5239668,351 ---- Majority: yes
Resolution 7 : To authorize the audit committee to determine the U.K. statutory auditors' remuneration for the year ending December 31, 2026. 38,293,2692,4818,090 ---- Majority: yes
Resolution 8 : To receive and adopt the U.K. statutory annual accounts and reports for the year ended December 31, 2025 (the "2025 U.K. 38,287,98794414,909 ---- Majority: yes
Resolution 9 : To approve the directors' remuneration report for the year ended December 31, 2025, which is set forth as Annex A to the Proxy Statement and on pages 26 to 56 of the 2025 U.K. Annual Report (excluding the directors' remunerat 29,504,6928,713,57385,575 ---- Majority: yes
Resolution 10 : To authorize the Company to make political donations/incur political expenditure. 38,213,34082,1138,387 ---- Majority: yes

Source: Immunocore Holdings Plc, Form 8-K, filed with the SEC on 2026-05-27 — read the filing on EDGAR.

How asset managers voted at the Immunocore Holdings Plc 2025-2026 meeting

Each item below shows how the 156 asset managers that disclosed a Immunocore Holdings Plc vote in their SEC Form N-PX filings actually voted. Share totals are the shares those managers' funds voted, summed across every fund they report. These are reported items, not a count of the ballot: fund filings describe one ballot item in different words. Two descriptions are shown as one item only on evidence — the same text (or one cut short of the other), the same director nominee, or a match to the same row of Immunocore Holdings Plc’s own Form 8-K tally — never because they merely read alike. A description that could not be joined that way is listed on its own, so one ballot item can appear more than once.

1. To approve, on advisory basis, the compensation of the Company's named executive officers, as disclosed in the proxy statement.

SECTION 14A SAY-ON-PAY VOTESMajority of the votes cast: yes

Combines 7 wordings of this item as funds reported it.

78% Majority: yes · of votes cast

FOR 78%AGAINST 22%
FOR: 29,682,169AGAINST: 8,600,029

Immunocore Holdings Plc’s own tally for this item (“Resolution 4: To approve, on an advisory basis, the compensation of the Company's named executive officers, as disclosed in the Proxy Statement.”): 29,682,169 for, 8,600,029 against, per its Form 8-K filed 2026-05-27 (Item 5.07). FOR was more than half of the votes cast. Whether the item passed is for the filing to say; its statement has not been read for this item. Of all 50,865,574 outstanding shares: 58% for, 17% against (75% of the company cast a for/against vote).

The 154 asset managers below cast 88% of the shares they voted on this item FOR. Fund share totals are not shown for this item: fund-reported shares overlap across filings (an adviser and the funds it manages can each report the same shares), and here their sum exceeds the total votes cast at the meeting.

FOR 87%12%
FOR: 86.6%AGAINST: 11.5%ABSTAIN: 1.9%
Largest asset managers voting on “To approve, on advisory basis, the compensation of the Company's named executive officers, as disclosed in the” at Immunocore Holdings Plc, 2025-2026
Asset managerForAgainst AbstainWithheldVote
Fidelity7,782,7180 00For
Vanguard4,959,5502,144 00For
RTW INVESTMENTS, LP4,869,7980 00For
T. Rowe Price3,688,9391,364 00For
Wellington3,441,8400 00For
PRIMECAP MANAGEMENT CO/CA/3,433,5010 00For
Vestal Point Capital, LP01,972,943 00Against
Deep Track Capital, LP1,921,8730 00For
Logos Global Management LP1,450,0000 00For
BVF INC/IL1,294,4630 00For
Janus Henderson1,189,4240 00For
PRIMECAP Odyssey Funds1,142,8000 00For
Kynam Capital Management, LP00 884,9370Abstain
ARMISTICE CAPITAL, LLC655,0920 00For
Two Sigma0651,888 00Against
BlackRock604,800352 00For
Fiera Capital Corp0594,751 00Against
Point720407,648 00Against
MASSACHUSETTS FINANCIAL SERVICES CO /MA/407,3730 00For
MFS407,3730 00For
Hudson Bay Capital Management LP0350,766 00Against
PRINCIPAL GLOBAL INVESTORS330,5180 00For
Woodline Partners LP283,5080 00For
Candriam S.C.A.0269,729 00Against
Principal239,0000 00For

Showing the 25 largest of 154 asset managers. See all 154 in the interactive database.

2. To approve our directors' remuneration report for the year ended December 31, 2025, which is set forth as Annex A to the attached proxy statement and on pages 26 to 56 of the 2025 U.K. Annual Report (excluding the directors' remuneration policy set out on 26 to 56 2025 U.K. Annual Report (excluding the directors' remuneration policy set out on A7 to A18 of Annex A).

COMPENSATIONMajority of the votes cast: yes

Combines 5 wordings of this item as funds reported it.

77% Majority: yes · of votes cast

FOR 77%AGAINST 23%
FOR: 29,504,692AGAINST: 8,713,573

Immunocore Holdings Plc’s own tally for this item (“Resolution 9 : To approve the directors' remuneration report for the year ended December 31, 2025, which is set forth as Annex A to the Proxy Statement and on pages 26 to 56 of the 2025 U.K. Annual Report (excluding the ”): 29,504,692 for, 8,713,573 against, per its Form 8-K filed 2026-05-27 (Item 5.07). FOR was more than half of the votes cast. Whether the item passed is for the filing to say; its statement has not been read for this item. Of all 50,865,574 outstanding shares: 58% for, 17% against (75% of the company cast a for/against vote).

The 38 asset managers below cast 94% of the shares they voted on this item FOR (12,088,188 for, 785,382 against).

FOR 93%
FOR: 12,088,188 (93.4%)AGAINST: 785,382 (6.1%)ABSTAIN: 65,130 (0.5%)
Largest asset managers voting on “To approve our directors' remuneration report for the year ended December 31, 2025, which is set forth as Anne” at Immunocore Holdings Plc, 2025-2026
Asset managerForAgainst AbstainWithheldVote
Vanguard4,959,5500 00For
Fidelity3,062,2940 00For
T. Rowe Price1,423,7020 00For
PRIMECAP Odyssey Funds1,142,8000 00For
BlackRock604,800352 00For
Fiera Capital Corp0594,751 00Against
MFS407,3730 00For
Principal239,0000 00For
Hartford96,2330 00For
HUSSMAN INVESTMENT TRUST00 60,0000Abstain
New York Life057,881 00Against
STEWARD FUNDS, INC.035,726 00Against
Tema ETF Trust30,6510 00For
Lord Abbett028,532 00Against
Northwestern Mutual26,5530 00For
Equitable12,62713,700 00Against
Pacific Life25,0520 00For
John Hancock23,9440 00For
OLD WESTBURY FUNDS INC022,978 00Against
PRINCIPAL VARIABLE CONTRACTS FUNDS INC20,5000 00For
AIG/SunAmerica08,302 00Against
Empower05,912 00Against
Brighthouse00 5,1300Abstain
State Street4,9510 00For
Blackstone Alternative Investment Funds04,600 00Against

Showing the 25 largest of 38 asset managers. See all 38 in the interactive database.

3. To authorize the audit committee to determine the U.K. statutory auditors' remuneration for the year ending 31 December 2026.

AUDIT-RELATEDMajority of the votes cast: yes

Combines 3 wordings of this item as funds reported it.

99.9% Majority: yes · of votes cast

FOR 99.9%
FOR: 38,293,269AGAINST: 2,481

Immunocore Holdings Plc’s own tally for this item (“Resolution 7 : To authorize the audit committee to determine the U.K. statutory auditors' remuneration for the year ending December 31, 2026.”): 38,293,269 for, 2,481 against, per its Form 8-K filed 2026-05-27 (Item 5.07). FOR was more than half of the votes cast. Whether the item passed is for the filing to say; its statement has not been read for this item. Of all 50,865,574 outstanding shares: 75% for, 0.1% against (75% of the company cast a for/against vote).

The 35 asset managers below cast 100% of the shares they voted on this item FOR (12,283,002 for, 0 against).

FOR 99.9%
FOR: 12,283,002 (100.0%)ABSTAIN: 5,130 (0.0%)
Largest asset managers voting on “To authorize the audit committee to determine the U.K. statutory auditors' remuneration for the year ending 31” at Immunocore Holdings Plc, 2025-2026
Asset managerForAgainst AbstainWithheldVote
Vanguard4,959,5500 00For
Fidelity3,062,2940 00For
T. Rowe Price1,423,7020 00For
PRIMECAP Odyssey Funds1,142,8000 00For
BlackRock550,6210 00For
MFS407,3730 00For
Principal239,0000 00For
Hartford96,2330 00For
HUSSMAN INVESTMENT TRUST60,0000 00For
New York Life57,8810 00For
STEWARD FUNDS, INC.35,7260 00For
Tema ETF Trust30,6510 00For
Lord Abbett28,5320 00For
Northwestern Mutual26,5530 00For
Equitable26,3270 00For
Pacific Life25,0520 00For
John Hancock23,9440 00For
OLD WESTBURY FUNDS INC22,9780 00For
PRINCIPAL VARIABLE CONTRACTS FUNDS INC20,5000 00For
AIG/SunAmerica8,3020 00For
Empower5,9120 00For
Brighthouse00 5,1300Abstain
State Street4,9510 00For
Blackstone Alternative Investment Funds4,6000 00For
ALPS ETF Trust4,1270 00For

Showing the 25 largest of 35 asset managers. See all 35 in the interactive database.

4. To authorize the Company to make political donations/incur political expenditure.

OTHER SOCIAL ISSUESMajority of the votes cast: yes

Combines 4 wordings of this item as funds reported it.

99.7% Majority: yes · of votes cast

FOR 99.7%
FOR: 38,213,340AGAINST: 82,113

Immunocore Holdings Plc’s own tally for this item (“Resolution 10 : To authorize the Company to make political donations/incur political expenditure.”): 38,213,340 for, 82,113 against, per its Form 8-K filed 2026-05-27 (Item 5.07). FOR was more than half of the votes cast. Whether the item passed is for the filing to say; its statement has not been read for this item. Of all 50,865,574 outstanding shares: 75% for, 0.2% against (75% of the company cast a for/against vote).

The 35 asset managers below cast 99.0% of the shares they voted on this item FOR (12,223,002 for, 120,000 against).

FOR 99%
FOR: 12,223,002 (99.0%)AGAINST: 120,000 (1.0%)ABSTAIN: 5,130 (0.0%)
Largest asset managers voting on “To authorize the Company to make political donations/incur political expenditure.” at Immunocore Holdings Plc, 2025-2026
Asset managerForAgainst AbstainWithheldVote
Vanguard4,959,5500 00For
Fidelity3,062,2940 00For
T. Rowe Price1,423,7020 00For
PRIMECAP Odyssey Funds1,142,8000 00For
BlackRock550,6210 00For
MFS407,3730 00For
Principal239,0000 00For
HUSSMAN INVESTMENT TRUST0120,000 00Against
Hartford96,2330 00For
New York Life57,8810 00For
STEWARD FUNDS, INC.35,7260 00For
Tema ETF Trust30,6510 00For
Lord Abbett28,5320 00For
Northwestern Mutual26,5530 00For
Equitable26,3270 00For
Pacific Life25,0520 00For
John Hancock23,9440 00For
OLD WESTBURY FUNDS INC22,9780 00For
PRINCIPAL VARIABLE CONTRACTS FUNDS INC20,5000 00For
AIG/SunAmerica8,3020 00For
Empower5,9120 00For
Brighthouse00 5,1300Abstain
State Street4,9510 00For
Blackstone Alternative Investment Funds4,6000 00For
ALPS ETF Trust4,1270 00For

Showing the 25 largest of 35 asset managers. See all 35 in the interactive database.

5. To re-appoint Deloitte LLP, a limited liability partnership organized under the laws of England, as our U.K. statutory auditors, to hold office until the conclusion of our next annual general meeting of shareholders.

AUDIT-RELATEDMajority of the votes cast: yes

Combines 3 wordings of this item as funds reported it.

99.9% Majority: yes · of votes cast

FOR 99.9%
FOR: 38,294,523AGAINST: 966

Immunocore Holdings Plc’s own tally for this item (“Resolution 6 : To re-appoint Deloitte LLP, a limited liability partnership organized under the laws of England, as the Company's U.K. statutory auditors, to hold office until the conclusion of the next annual general mee”): 38,294,523 for, 966 against, per its Form 8-K filed 2026-05-27 (Item 5.07). FOR was more than half of the votes cast. Whether the item passed is for the filing to say; its statement has not been read for this item. Of all 50,865,574 outstanding shares: 75% for, 0.1% against (75% of the company cast a for/against vote).

The 35 asset managers below cast 100% of the shares they voted on this item FOR (12,283,002 for, 0 against).

FOR 99.9%
FOR: 12,283,002 (100.0%)ABSTAIN: 5,130 (0.0%)
Largest asset managers voting on “To re-appoint Deloitte LLP, a limited liability partnership organized under the laws of England, as our U.K. s” at Immunocore Holdings Plc, 2025-2026
Asset managerForAgainst AbstainWithheldVote
Vanguard4,959,5500 00For
Fidelity3,062,2940 00For
T. Rowe Price1,423,7020 00For
PRIMECAP Odyssey Funds1,142,8000 00For
BlackRock550,6210 00For
MFS407,3730 00For
Principal239,0000 00For
Hartford96,2330 00For
HUSSMAN INVESTMENT TRUST60,0000 00For
New York Life57,8810 00For
STEWARD FUNDS, INC.35,7260 00For
Tema ETF Trust30,6510 00For
Lord Abbett28,5320 00For
Northwestern Mutual26,5530 00For
Equitable26,3270 00For
Pacific Life25,0520 00For
John Hancock23,9440 00For
OLD WESTBURY FUNDS INC22,9780 00For
PRINCIPAL VARIABLE CONTRACTS FUNDS INC20,5000 00For
AIG/SunAmerica8,3020 00For
Empower5,9120 00For
Brighthouse00 5,1300Abstain
State Street4,9510 00For
Blackstone Alternative Investment Funds4,6000 00For
ALPS ETF Trust4,1270 00For

Showing the 25 largest of 35 asset managers. See all 35 in the interactive database.

6. To ratify the appointment of Deloitte LLP, a limited liability partnership organized under the laws of England, as our U.S. independent registered public accounting firm for the year ending 31 December 2026.

AUDIT-RELATEDMajority of the votes cast: yes

Combines 2 wordings of this item as funds reported it.

99.9% Majority: yes · of votes cast

FOR 99.9%
FOR: 38,294,666AGAINST: 984

Immunocore Holdings Plc’s own tally for this item (“Resolution 5: To ratify the appointment of Deloitte LLP, a limited liability partnership organized under the laws of England, as the Company's U.S. independent registered public accounting firm for the year ending Decemb”): 38,294,666 for, 984 against, per its Form 8-K filed 2026-05-27 (Item 5.07). FOR was more than half of the votes cast. Whether the item passed is for the filing to say; its statement has not been read for this item. Of all 50,865,574 outstanding shares: 75% for, 0.1% against (75% of the company cast a for/against vote).

The 35 asset managers below cast 100% of the shares they voted on this item FOR (11,961,102 for, 0 against).

FOR 99.9%
FOR: 11,961,102 (100.0%)ABSTAIN: 5,130 (0.0%)
Largest asset managers voting on “To ratify the appointment of Deloitte LLP, a limited liability partnership organized under the laws of England” at Immunocore Holdings Plc, 2025-2026
Asset managerForAgainst AbstainWithheldVote
Vanguard4,959,5500 00For
Fidelity3,062,2940 00For
T. Rowe Price1,423,7020 00For
PRIMECAP Odyssey Funds1,142,8000 00For
MFS407,3730 00For
Principal239,0000 00For
BlackRock228,7210 00For
Hartford96,2330 00For
HUSSMAN INVESTMENT TRUST60,0000 00For
New York Life57,8810 00For
STEWARD FUNDS, INC.35,7260 00For
Tema ETF Trust30,6510 00For
Lord Abbett28,5320 00For
Northwestern Mutual26,5530 00For
Equitable26,3270 00For
Pacific Life25,0520 00For
John Hancock23,9440 00For
OLD WESTBURY FUNDS INC22,9780 00For
PRINCIPAL VARIABLE CONTRACTS FUNDS INC20,5000 00For
AIG/SunAmerica8,3020 00For
Empower5,9120 00For
Brighthouse00 5,1300Abstain
State Street4,9510 00For
Blackstone Alternative Investment Funds4,6000 00For
ALPS ETF Trust4,1270 00For

Showing the 25 largest of 35 asset managers. See all 35 in the interactive database.

7. To re-appoint Kristine Peterson as a director who retires in accordance with the articles of association.

DIRECTOR ELECTIONSMajority of the votes cast: yes

Combines 3 wordings of this item as funds reported it.

77% Majority: yes · of votes cast

FOR 77%AGAINST 23%
FOR: 29,537,800AGAINST: 8,744,383

Immunocore Holdings Plc’s own tally for this item (“Resolution 3 : To re-appoint as a director of the Company Kristine Peterson.”): 29,537,800 for, 8,744,383 against, per its Form 8-K filed 2026-05-27 (Item 5.07). FOR was more than half of the votes cast. Whether the item passed is for the filing to say; its statement has not been read for this item. Of all 50,865,574 outstanding shares: 58% for, 17% against (75% of the company cast a for/against vote).

The 35 asset managers below cast 94% of the shares they voted on this item FOR (11,271,186 for, 749,916 against).

FOR 94%
FOR: 11,271,186 (93.7%)AGAINST: 749,916 (6.2%)ABSTAIN: 5,130 (0.0%)
Largest asset managers voting on “To re-appoint Kristine Peterson as a director who retires in accordance with the articles of association.” at Immunocore Holdings Plc, 2025-2026
Asset managerForAgainst AbstainWithheldVote
Vanguard4,959,5500 00For
Fidelity3,062,2940 00For
T. Rowe Price1,423,7020 00For
PRIMECAP Odyssey Funds1,142,8000 00For
MFS0407,373 00Against
Principal0239,000 00Against
BlackRock228,7210 00For
HUSSMAN INVESTMENT TRUST120,0000 00For
Hartford96,2330 00For
New York Life57,8810 00For
STEWARD FUNDS, INC.035,726 00Against
Tema ETF Trust30,6510 00For
Lord Abbett28,5320 00For
Northwestern Mutual26,5530 00For
Equitable26,3270 00For
Pacific Life25,0520 00For
John Hancock23,9440 00For
OLD WESTBURY FUNDS INC022,978 00Against
PRINCIPAL VARIABLE CONTRACTS FUNDS INC020,500 00Against
AIG/SunAmerica08,302 00Against
Empower5,9120 00For
Brighthouse00 5,1300Abstain
State Street4,9510 00For
Blackstone Alternative Investment Funds04,600 00Against
ALPS ETF Trust04,127 00Against

Showing the 25 largest of 35 asset managers. See all 35 in the interactive database.

8. To re-appoint William Pao, M.D., Ph.D. as a director who retires in accordance with the articles of association.

DIRECTOR ELECTIONSMajority of the votes cast: yes

Combines 3 wordings of this item as funds reported it.

99.3% Majority: yes · of votes cast

FOR 99.3%
FOR: 38,040,755AGAINST: 254,852

Immunocore Holdings Plc’s own tally for this item (“Resolution 2 : To re-appoint as a director of the Company William Pao, M.D., Ph.D.”): 38,040,755 for, 254,852 against, per its Form 8-K filed 2026-05-27 (Item 5.07). FOR was more than half of the votes cast. Whether the item passed is for the filing to say; its statement has not been read for this item. Of all 50,865,574 outstanding shares: 75% for, 0.6% against (75% of the company cast a for/against vote).

The 35 asset managers below cast 100% of the shares they voted on this item FOR (12,021,102 for, 0 against).

FOR 99.9%
FOR: 12,021,102 (100.0%)ABSTAIN: 5,130 (0.0%)
Largest asset managers voting on “To re-appoint William Pao, M.D., Ph.D. as a director who retires in accordance with the articles of associatio” at Immunocore Holdings Plc, 2025-2026
Asset managerForAgainst AbstainWithheldVote
Vanguard4,959,5500 00For
Fidelity3,062,2940 00For
T. Rowe Price1,423,7020 00For
PRIMECAP Odyssey Funds1,142,8000 00For
MFS407,3730 00For
Principal239,0000 00For
BlackRock228,7210 00For
HUSSMAN INVESTMENT TRUST120,0000 00For
Hartford96,2330 00For
New York Life57,8810 00For
STEWARD FUNDS, INC.35,7260 00For
Tema ETF Trust30,6510 00For
Lord Abbett28,5320 00For
Northwestern Mutual26,5530 00For
Equitable26,3270 00For
Pacific Life25,0520 00For
John Hancock23,9440 00For
OLD WESTBURY FUNDS INC22,9780 00For
PRINCIPAL VARIABLE CONTRACTS FUNDS INC20,5000 00For
AIG/SunAmerica8,3020 00For
Empower5,9120 00For
Brighthouse00 5,1300Abstain
State Street4,9510 00For
Blackstone Alternative Investment Funds4,6000 00For
ALPS ETF Trust4,1270 00For

Showing the 25 largest of 35 asset managers. See all 35 in the interactive database.

9. To receive and adopt the U.K. statutory annual accounts and reports for the year ended 31 December 2025.

CORPORATE GOVERNANCEMajority of the votes cast: yes

Combines 2 wordings of this item as funds reported it.

99.9% Majority: yes · of votes cast

FOR 99.9%
FOR: 38,287,987AGAINST: 944

Immunocore Holdings Plc’s own tally for this item (“Resolution 8 : To receive and adopt the U.K. statutory annual accounts and reports for the year ended December 31, 2025 (the "2025 U.K.”): 38,287,987 for, 944 against, per its Form 8-K filed 2026-05-27 (Item 5.07). FOR was more than half of the votes cast. Whether the item passed is for the filing to say; its statement has not been read for this item. Of all 50,865,574 outstanding shares: 75% for, 0.1% against (75% of the company cast a for/against vote).

The 35 asset managers below cast 100% of the shares they voted on this item FOR (11,961,102 for, 0 against).

FOR 99.9%
FOR: 11,961,102 (100.0%)ABSTAIN: 5,130 (0.0%)
Largest asset managers voting on “To receive and adopt the U.K. statutory annual accounts and reports for the year ended 31 December 2025.” at Immunocore Holdings Plc, 2025-2026
Asset managerForAgainst AbstainWithheldVote
Vanguard4,959,5500 00For
Fidelity3,062,2940 00For
T. Rowe Price1,423,7020 00For
PRIMECAP Odyssey Funds1,142,8000 00For
MFS407,3730 00For
Principal239,0000 00For
BlackRock228,7210 00For
Hartford96,2330 00For
HUSSMAN INVESTMENT TRUST60,0000 00For
New York Life57,8810 00For
STEWARD FUNDS, INC.35,7260 00For
Tema ETF Trust30,6510 00For
Lord Abbett28,5320 00For
Northwestern Mutual26,5530 00For
Equitable26,3270 00For
Pacific Life25,0520 00For
John Hancock23,9440 00For
OLD WESTBURY FUNDS INC22,9780 00For
PRINCIPAL VARIABLE CONTRACTS FUNDS INC20,5000 00For
AIG/SunAmerica8,3020 00For
Empower5,9120 00For
Brighthouse00 5,1300Abstain
State Street4,9510 00For
Blackstone Alternative Investment Funds4,6000 00For
ALPS ETF Trust4,1270 00For

Showing the 25 largest of 35 asset managers. See all 35 in the interactive database.

10. To re-appoint Siddharth Kaul as a director who retires in accordance with the articles of association.

DIRECTOR ELECTIONS

Combines 2 wordings of this item as funds reported it.

100% fund support · no official result

FOR 99.9%

The 34 asset managers below cast 100% of the shares they voted on this item FOR (11,901,102 for, 0 against).

FOR: 11,901,102 (100.0%)ABSTAIN: 5,130 (0.0%)
Largest asset managers voting on “To re-appoint Siddharth Kaul as a director who retires in accordance with the articles of association.” at Immunocore Holdings Plc, 2025-2026
Asset managerForAgainst AbstainWithheldVote
Vanguard4,959,5500 00For
Fidelity3,062,2940 00For
T. Rowe Price1,423,7020 00For
PRIMECAP Odyssey Funds1,142,8000 00For
MFS407,3730 00For
Principal239,0000 00For
BlackRock228,7210 00For
Hartford96,2330 00For
New York Life57,8810 00For
STEWARD FUNDS, INC.35,7260 00For
Tema ETF Trust30,6510 00For
Lord Abbett28,5320 00For
Northwestern Mutual26,5530 00For
Equitable26,3270 00For
Pacific Life25,0520 00For
John Hancock23,9440 00For
OLD WESTBURY FUNDS INC22,9780 00For
PRINCIPAL VARIABLE CONTRACTS FUNDS INC20,5000 00For
AIG/SunAmerica8,3020 00For
Empower5,9120 00For
Brighthouse00 5,1300Abstain
State Street4,9510 00For
Blackstone Alternative Investment Funds4,6000 00For
ALPS ETF Trust4,1270 00For
ETFis Series Trust I3,9450 00For

Showing the 25 largest of 34 asset managers. See all 34 in the interactive database.

Largest Immunocore Holdings Plc shareholders voting in 2025-2026

Ranked by the number of Immunocore Holdings Plc shares each manager voted on the most widely held ballot item of the 2025-2026 meeting, shown as a share of the 50,865,574 shares outstanding at the time of that meeting.

Top Immunocore Holdings Plc shareholders by shares voted, 2025-2026
#Asset manager % of shares outstanding
1Fidelity 15.30%
2Vanguard 9.75%
3RTW INVESTMENTS, LP 9.57%
4T. Rowe Price 7.26%
5Wellington 6.77%
6PRIMECAP MANAGEMENT CO/CA/ 6.75%
7Vestal Point Capital, LP 3.88%
8Deep Track Capital, LP 3.78%
9Logos Global Management LP 2.85%
10BVF INC/IL 2.54%

Reported Immunocore Holdings Plc ownership

Positions disclosed to the SEC on Schedules 13D and 13G, Form 13F and the company’s own proxy statement (DEF 14A).

Immunocore Holdings Plc beneficial owners on record for the 2025-2026 proxy season
Holder % outstanding Disclosure
Bahija Jallal, Ph.D. 10.10% DEF14A
Entities affiliated with RTW 9.57% DEF14A
FMR (Fidelity) 9.49% 13F
Wellington Management 9.25% 13F
Entities affiliated with FMR LLC 8.62% DEF14A
PRIMECAP Management Company 7.42% DEF14A
Bellevue Asset Management AG 5.50% DEF14A
Entities affiliated with Tang Capital 5.12% DEF14A
Vestal Point Capital, LP 3.54% 13G
Point72 2.17% 13F

Percentages above are of 50,865,574 shares outstanding, as reported by Immunocore Holdings Plc on its Form 10-Q dated 2026-04-30 (see the filing on EDGAR). This is the count contemporaneous with the 2025-2026 meeting, so the percentages are the ones that were true then, not ones restated against today’s share count.

About this page

Every figure above is derived from filings made with the US Securities and Exchange Commission: Form N-PX, in which registered investment companies and institutional managers disclose how they voted every proxy, and Form 8-K Item 5.07, in which the company reports its own meeting results. Shares outstanding are taken from Immunocore Holdings Plc’s 10-Q dated 2026-04-30. This page is a static snapshot rebuilt weekly on 02 October 2026; a live search always shows the current data.

At Immunocore Holdings Plc's shareholder meeting held 2026-05-27, in the 2025-2026 proxy season, 156 asset managers reported how they voted in their SEC Form N-PX filings, covering 879 separate fund positions. Their filings are grouped here into 10 reported items; because filers word the same ballot item differently, that can be more than the number of items on the ballot. On the most widely held item on that ballot — To approve, on advisory basis, the compensation of the Company's named executive officers, as… — FOR was 78% of the votes cast (FOR divided by FOR plus AGAINST, the conventional basis for proxy support; abstentions, broker non-votes and unvoted shares are excluded because none of them took a side), which is more than half. Whether the item was approved is for the filing to say; that statement has not been read for this item. Source: Immunocore Holdings Plc's Form 8-K, Item 5.07, filed with the U.S. Securities and Exchange Commission on 2026-05-27.

Immunocore Holdings Plc proxy season coverage: 2023-2024 · 2024-2025 · 2025-2026 (this page).